Parkinson Clinical Trials

10 recruiting

Parkinson Trials at a Glance

691 actively recruiting trials for parkinson are listed on ClinicalTrialsFinder across 6 cities in 50 countries. The largest study group is Not Applicable with 337 trials, with the heaviest enrollment activity in Boston, New York, and Nashville. Lead sponsors running parkinson studies include University of Minnesota, VA Office of Research and Development, and Vanderbilt University Medical Center.

Treatments under study

About Parkinson Clinical Trials

Looking for clinical trials for Parkinson? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Parkinson trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Parkinson clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 691 trials

Recruiting
Not Applicable

Deep Brain Stimulation Therapy in Movement Disorders

Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS)300 enrolled1 locationNCT02119611
Recruiting
Phase 3

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Parkinsons Disease (PD)
BlueRock Therapeutics102 enrolled39 locationsNCT06944522
Recruiting
Not Applicable

The Effect of Long-term Daily Stimulation of the Brain With Pulsed Electromagnetic Fields on Parkinsons Disease

PARKINSON DISEASE (Disorder)
University of Southern Denmark90 enrolled2 locationsNCT07306104
Recruiting
Phase 2Phase 3

A Study of Buntanetap in Participants With PD

Deep Brain StimulationParkinson's Disease (PD)
Annovis Bio Inc.500 enrolled27 locationsNCT07284784
Recruiting
Not Applicable

Brain Training to Improve Balance in Parkinson's Disease

Parkinson Disease
University of Leicester100 enrolled1 locationNCT05986643
Recruiting
Not Applicable

tDCS on Parkinson's Disease Cognition

Parkinson DiseaseMild Cognitive Impairment
University of Manitoba36 enrolled1 locationNCT03025334
Recruiting
Not Applicable

Auditory Sleep Stimulation or Sham in People With Parkinson Disease Mild Cognitive Impairment During Cognitive Training

Mild Cognitive ImpairmentParkinson's Disease
University of Zurich50 enrolled1 locationNCT07441915
Recruiting
Not Applicable

Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

PARKINSON DISEASE (Disorder)
University of Alabama at Birmingham24 enrolled1 locationNCT07557706
Recruiting
Phase 1Phase 2

The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

Parkinson Disease
University of Alabama at Birmingham205 enrolled1 locationNCT03457493
Recruiting
Not Applicable

Deep Brain Stimulation Surgery for Movement Disorders

DystoniaParkinson's DiseaseEssential Tremor
National Institute of Neurological Disorders and Stroke (NINDS)200 enrolled1 locationNCT01581580
Recruiting
Not Applicable

Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients

Parkinson's Disease and Parkinsonism
Samsung Medical Center60 enrolled1 locationNCT06350617
Recruiting

World Data on Ambroxol for Patients With GD and GBA Related PD

Gaucher DiseaseParkinson DiseaseGBA Gene Mutation
Shaare Zedek Medical Center300 enrolled3 locationsNCT04388969
Recruiting
Phase 1

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

DementiaParkinson's Disease
National Institute of Mental Health (NIMH)184 enrolled1 locationNCT04396873
Recruiting
Not Applicable

Short and Long-term Responses of PD Symptoms to Earstim

PARKINSON DISEASE (Disorder)
Stoparkinson Healthcare Systems LLC90 enrolled2 locationsNCT07400731
Recruiting

Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

Parkinson DiseaseBrain DiseaseSynucleinopathies+2 more
Azienda USL Reggio Emilia - IRCCS150 enrolled1 locationNCT07187843
Recruiting
Phase 2

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Parkinson DiseaseParkinsonParkinson Disease, Idiopathic+2 more
Neuron23 Inc.150 enrolled70 locationsNCT06680830
Recruiting
Not Applicable

Retinal Hyperspectral Imaging in Neurodegenerative Diseases

DementiaAlzheimer DiseaseParkinson Disease+5 more
Center for Eye Research Australia930 enrolled1 locationNCT07545473
Recruiting
Not Applicable

Blood Pressure Effects on Cognition and Brain Blood Flow in PD

DysautonomiaParkinson DiseaseOrthostatic Hypotension
University of California, San Diego60 enrolled1 locationNCT05400174
Recruiting
Phase 1

SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

PARKINSON DISEASE (Disorder)Advanced Parkinson's Disease
Serina Therapeutics40 enrolled6 locationsNCT07422675
Recruiting

SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

Parkinson Disease
Bial - Portela C S.A.90 enrolled12 locationsNCT07145190